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ABSTRACT
Conclusion: There is urgent need of promotion of spontaneous reporting of ADRs. More awareness needs to be created to address these issues.
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INTRODUCTION
According to the WHO, adverse drug reaction (ADR) is defined as “any 
response which is noxious and unintended and occurs at dosages 
normally used in humans for prophylaxis, diagnosis, or therapy for 
disease or for the modification of physiological function” [1]. This 
includes allergies, idiosyncrasies, pharmacological and toxicological 
mechanisms, and interactions between medicines and excludes 
adverse reactions due to drug overdose (poisoning), drug abuse, and 
therapeutic errors. ADRs may arise as a result of immunological or non-
immunological mechanisms [2]. According to Rawlins and Thompsons 
classification, ADRs are defined as Type A, Type B, Type C, Type D, 
Type E, Type F, and Type G. Type A reaction is an over enhancement 
of the normal pharmacology of the medication and is predictable and 
related to dosage. Type B reaction is unrelated to normal pharmacology 
and is unpredictable. Type C reaction includes those associated with 
cumulative exposure to the drug and persists for a longer period of 
time. Type D reactions consist of delayed reaction of carcinogenesis and 
teratogenesis. Type E includes end of treatment effects and Type F is 
failure of therapy, while Type G consists of genetic reaction [3,4].
ADRs are important clinical problems and a constant concern of public 
health system. The incidence of ADRs in Indian population ranges 
between 1.8% and 25.1% with 8%, resulting in hospitalization [5]. 
Commonly prescribed medications such as antimicrobial agents (AMAs), 
analgesics and anti-inflammatory medicines, hypoglycemic medicines, 
diuretics, and anticoagulants are responsible for 60–70% of ADRs [6].
In India, a large number of pharmaceutical preparations - branded and 
generic - are available and there is a common practice of over the counter 
different systems of health-care traditions, and lack of awareness on 
rational drug use is expected to produce a high level of drug-induced 
illness [7]. There is a paucity of ADR data in Indian context, so here the 
role of pharmacovigilance comes. Pharmacovigilance is a science and 
activities relating to the detection, assessment, understanding, and 
prevention of adverse effects or any other medicine-related problem [8]. 
Hence, it is worthwhile to detect, assess, and characterize the pattern of 
ADRs in outpatient departments of tertiary care hospitals.
METHODS
A longitudinal, retrospective, observational study was conducted in 
patients attending outpatient department from January 2014 to March 
2016. All suspected ADRs of patients in the hospital were referred by 
health-care professionals, and the diagnosis was made by concern 
doctors. The data were recorded as per spontaneous ADR reporting 
system [9]. The recorded data were filled in the ADR form obtained 
from pharmacovigilance program of India (2011) and Central Drug 
Standard Control Organization website.
Patient’s gender, type of ADR, history of diseases, starting date of ADR, 
suspected drug causing ADR, primary source of ADR, concomitant 
medicines given, and reporting person’s initials (doctor, nurse, resident, 
physician, and pharmacist) were noted. The data were analyzed; 
causality assessment was done according to the WHO-UMC causality 
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To  reduce  these  large  percentage  of  ADRs  and  to  minimize 
physical,  mental,  and  economical  burden  over  patients  because  of 
ADRs, the 
assessment scale [10], severity assessment was done by Hartwig–
Siegel severity scale, and preventability assessment was performed by 
modified Thornton and Schumock scale. Respective physician of the 
institution helped in the process and data were analyzed using simple 
proportions method.
RESULTS
During the study period, a total of 1099 ADRs reported were analyzed.
Fig. 1 shows gender-wise distribution of ADRs. Male experienced 
a significantly higher percentage of ADRs (55.86%) than females 
(44.13%). Male-to-female ratio according to the occurrence of ADRs 
was 1.26.
Fig. 2 shows age-wise distribution of ADRs. The highest percentage of 
ADRs was found in adult age group 31–40 years, i.e., 377 (34.30%), 
more than 15 years of age (99%), and only 1% ADRs in age group 
<15 years. According to the WHO-UMC causality assessment scale, all 
ADRs were probable. There was no any certain ADR that could be found 
out.
Fig. 3 shows system-wise distribution of ADRs among OPD patients. 
Skin was the most common organ showing highest number of ADR 
(41.87%), second highest is gastrointestinal tract system (34.31%), 
central nervous system ADRs were 13.55%, and other miscellaneous 
ADRs were 12.59 including respiratory, cardiovascular system, renal, 
hematological, and musculoskeletal system.
Fig. 4 shows department-wise frequency of ADRs among study patients. 
Internal medicine was the most common department (28.33%) ADRs, 
the second most common department was ART (20.05%), and rest of 
the department were skin (19.96%), tuberculosis (TB) chest (10.02%), 
and psychiatry (7.35%).
Fig. 5 shows a common group of medicines causing ADRs. 
Drug-wise distribution of ADRs was antimicrobials (22.24%), 
analgesic (19.91%), ART (12.92%), anti-TB (9.74%), antipsychotic 
medicines (8.05%), antidiabetic medicines (7.83%), antiepileptic 
medicines (7.20%), antihypertensive medicines (5.93%), calcium 
(4.46%), and folic acid (4.23%).
Fig. 6 shows antimicrobials causing ADR. In the present study, of 
total AMAs causing ADRs (195), maximum number of ADRs were 
due to amoxicillin+clavulanic acid, i.e., 48 (24.61%), followed by 
amoxicillin 44 (22.56%), ciprofloxacin 26 (13.33%), and cotrimoxazole 
21 (10.76%).
Fig. 7 shows the most common medicines causing ADRs. Most common 
medicines causing ADRs were efavirenz 85, diclofenac sodium 61, 
amoxicillin+clavulanic acid 59, and rifampicin 44.
Table 1 shows symptom-wise classification of ADRs. In this 
study, common symptoms due to ADRs of medicines were itching 
174 (15.83%), skin rash 108 (9.82%), gastritis 104 (9.46%), headache 
72 (6.55%), and vomiting 68 (6.18%).
Fig. 8 shows Hartwig–Siegel severity scale. 72.70% were mild reactions, 
26.93% were moderate reactions, and 0.36% were severe ones. There 
were three serious ADRs, two Stevens–Johnson syndrome due to 
nevirapine and carbamazepine and third anaphylactic reaction due to 
injection ceftriaxone.
Table 2 shows modified Thornton and Schumock preventability scale. 
51.95% reactions were not preventable, whereas 40.85% reactions 
were possibly preventable.
DISCUSSION
In the present study, a total of 1099 ADRs were documented from 
a tertiary teaching care hospital of Central India. In this study, males 
experienced a significantly higher percentage of ADRs than females, a 
finding consistent to Shamna et al. [11]. Most of the patients in our study 
were in the age group of 31–40 years, whereas in Ramakrishnaiah et al., 
study most of the patients were in the age group of 41–60 years [5]. 
Distribution of ADRs according to the WHO-UMC causality assessment 
scale [10] showed that all ADRs were probable and none as a certain. 
Maximum ADRs were due to AMAs, a finding consistent with other 
studies [4]. This shows the importance of physician’s awareness to AMA-
Fig. 1: Gender-wise distribution of adverse drug reactions
Fig. 2: Age-wise distribution of adverse drug reactions
Fig. 3: System-wise distribution of adverse drug reactions
Fig. 4: Department-wise frequency of adverse drug reactions
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Among the various systems affected by ADRs, skin is the most common 
system showing 41.87% of ADR cases as it is the biggest organ in the 
body and GIT is the next system to affect in 34.31% of ADR cases as 
Among the various departments reporting ADRs, medicine is the most 
common department (28.33% ADRs) [11]; next, departments to report 
ADRs were ART (20.05%), skin (19.96%), and TB chest (10.02%). 
Fig. 5: Common group of medicines causing adverse drug reactions
Fig. 6: Common antimicrobials causing adverse drug reactions
Fig. 7: Most common medicines causing adverse drug reactions
related  ADRs  in  daily  life.  Since  the  ADR  manifestation  may  be 
similar  with  the  disease  course  and  increase  the  unnecessary 
investigations  and  results  in  undue  delay  to  proper  and  rational 
treatment.
31
majorityof medicines are given througoral route and CNS in 13.55% 
of ADR cases as few medicines cross blood brain barrier. This finding is 
similar to Indian studies [11,12].
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All these departments are allied to medicine and the treatment 
line is based on the medications only so these departments report 
maximum number of ADRs than surgical departments where surgery 
is the main treatment. Departments such as ART, skin and TB include 
chronic infectious conditions which require the use of combination 
of medicines for prolonged duration. Increase in number of drugs 
per prescription increases the chances of drug interaction and leads 
to causation of ADR increasing the morbidity and mortality and cost 
of drug treatment. The attributable financial burden of drug-related 
morbidity and mortality is around Rs. 690 (US $15) per ADR [13]. In this 
study, the most common group of medicines causing ADRs was AMAs, 
analgesics, ARTs, anti-TB, antipsychotic, antidiabetics, antiepileptic, 
and antihypertensives. Amoxicillin-clavulanic acid (45%) was the most 
common antimicrobial used followed by amoxicillin (42%). Majority 
of patients treated in hospitals received at least one antibiotic and a 
significant proportion of them either receive two or more which leads 
to increased chances of ADRs in patients [14]. According to modified 
Hartwig and Siegel severity scale, 72.70% were mild reactions majority 
consisted that of itching, diarrhea, and metallic taste, 26.93% were 
moderate reactions such as drug eruptions, some cases of pain in 
abdomen, and angioedema, and 0.36% were severe reactions which 
included immediate hospitalization and prompt treatment. A severe 
ADR is “any untoward medical occurrence that at any dose results in 
death, requires hospital admission or prolongation of existing hospital 
stay, results in persistent or significant disability/incapacity, or is life 
threatening [15].” Two cases were of Steven–Johnsons syndrome due 
to nevirapine and carbamazepine, and a case was of anaphylactic 
shock due to injection ceftriaxone. Shamna et al. showed 8% of severe 
reactions, whereas it was 5% for Yerramilli et al. [16]. According to 
modified Thornton and Schumock preventability assessment scale, 
64.28% reactions were not preventable in pediatric age group as 
oppose to De Las Salas et al., whereas 98.7% were not preventable in 
children [17]. Non-preventable reactions may be non-predictable and 
may occur after a single dose, caused by immunological abnormality 
(drug allergy), inherited genetic abnormalities (idiosyncrasy). 
Measures to decrease the severity of the non-preventable ADRs are 
the use of proper resuscitative measures and apt supportive measures 
and quick identification of ADR that is by taking appropriate drug 
history, studying patient’s case records, selecting alternative drug 
with different chemical structure, and symptomatic treatment of the 
patients. Sensitivity tests must be performed while using penicillins, 
ester-linked local anesthetics, various anti-seras such as ATS, ADS, and 
ASV, and iodine-containing radio-contrast media. In our study, 45.40% Fig. 8: Hartwig-Siegel severity assessment scale
Table 1: Symptom-wise classification of ADRs
S. No. Symptom Number of ADRs (%)
1 Itching 174 (15.83)
2 Skin rash 108 (9.82)
3 Gastritis 104 (9.46)
4 Headache 72 (6.55)
5 Vomiting 68 (6.18)
6 Nausea 43 (3.91)
7 Anemia 43 (3.91)
8 Constipation 43 (3.91)
9 Mouth ulceration 41 (3.73)
10 Diarrhea 33 (3)
11 Drug eruption 33 (3)
12 Disorientation 32 (2.91)
13 Joint pain 24 (2.18)
14 Acne 21 (1.91)
15 Gynecomastia 16 (1.45)
16 Pain in abdomen 16 (1.45)
17 Metallic taste 15 (1.36)
18 Dry mouth 12 (1.09)
19 Angioedema 8 (0.72)
20 Giddiness 8 (0.72)
21 Weight gain 2 (0.18)
22 Anaphylactic shock 2 (0.18)
23 Steven–Johnson syndrome 2 (0.18)
ADRs: Adverse drug reaction
Table 2: Modified Thornton and Schumock preventability scale
Age-group Definitely preventable (%) Possibly preventable (%) Non-preventable (%)
Pediatric (up till 12 years) 0 10 (0.9) 18 (1.63)
Adult (13–60 years) 76 (6.91) 399 (36.3) 498 (45.31)
Geriatric (>60 years) 3 (0.27) 40 (3.63) 55 (5)
Gender
Male 50 (4.54) 261 (23.74) 158 (14.37)
Female 29 (2.63) 188 (17.1) 413 (37.57)
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of reactions were possibly preventable, whereas Tiwari et al. quoted 
5% reactions in this category [18]. These can be minimized by routinely 
monitoring the patients, by early diagnosis, and by best possible drugs 
with different group. Patients should be kept under strict surveillance 
when prescribed with notorious medicines such as oral anticoagulants 
and oral hypoglycemics and drugs with narrow therapeutic index and 
medicines affecting the vital functions.
CONCLUSION
Majors that help to minimize the ADRs are proper and essential 
laboratory monitoring, genetic testing (G6PD deficiency and human 
leukocyte antigen testing), patient education for any untoward or any 
undesired symptom or reaction so that they actively report at the 
earliest, early recognition, and reporting of ADR. Dying from disease 
is sometimes acceptable, but dying from drug is never acceptable, 
so culture should be cultivated to report ADRs. Awareness regarding 
reporting of ADRs among all health-care professionals, patients, and 
their relatives is of utmost importance. In the era of modern medicine, 
the patient should be treated with the optimal use of medicines as 
medicines are very hands of Gods if they are used prudently.
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